Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRyan, Edward T-
dc.description.abstractIn The Lancet Infectious Diseases, Amit Arjyal and colleagues report the results from their randomised clinical trial comparing gatifl oxacin with ceftriaxone for patients with uncomplicated enteric fever in Nepal. Their two main fi ndings are sobering. First, they suggest that fl uoroquinolones should no longer be recommended as front-line empirical treatment for individuals with enteric fever in Nepal. Second, a large proportion of individuals in Nepal who are syndromically characterised as having uncomplicated enteric fever probably have an alternative diagnosis.en_US
dc.publisherLancet Infect Dis 2016en_US
dc.subjectEnteric Fever:en_US
dc.titleTroubling news from Asia about treating enteric fever: a coming stormen_US
dc.typeTechnical Reporten_US
Appears in Collections:Research Abstract

Files in This Item:
File Description SizeFormat 
Troubling news from Asia about treating enteric fever.pdfFull Text Down Load.101.8 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.